The Basics

What is Clofazimine?

Indicated for the treatment of lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum.

Brand names for Clofazimine

Lamprene

How Clofazimine is classified

Leprostatic Agents

Clofazimine During Pregnancy

Clofazimine pregnancy category

Category N/ANote that the FDA has deprecated the use of pregnancy categories, so for some medications, this information isn’t available. We still think it’s useful to list historical info, however, given what a common proxy this has been in the past.

What we know about taking Clofazimine while pregnant

There are no data with LAMPRENE use in pregnant women to inform associated risk. Retardation of fetal skull ossification, increased incidences of abortions and stillbirths, and impaired neonatal survival were observed in mice following prenatal exposure to LAMPRENE at 25 mg/kg, equivalent to the 0.6 times maximum recommended human daily dose (200 mg), based on body surface area comparisons. Advise pregnant women of the potential risk to the fetus. The background risk of major birth defects and miscarriage for the indicated population is unknown; however, in the U.S. general population, the estimated background risk of major birth defects is 2-4% and of miscarriage is 15-20% of clinically recognized pregnancies.

Taking Clofazimine While Breastfeeding

What are recommendations for lactation if you're taking Clofazimine?

Limited information indicates that clofazimine appears in milk in relatively large amounts. Milk can be colored pink by the drug and breastfed infant’s skin can be discolored the typical red color that is common in persons taking the drug. No serious or permanent toxicity has been reported in breastfed infants; however, an alternate drug might be considered.

Maternal / infant drug levels

Limited information indicates that clofazimine appears in milk in relatively large amounts. Milk can be colored pink by the drug and breastfed infant’s skin can be discolored the typical red color that is common in persons taking the drug. No serious or permanent toxicity has been reported in breastfed infants; however, an alternate drug might be considered.

Possible effects of Clofazimine on milk supply

Relevant published information was not found as of the revision date.

Possible alternatives to Clofazimine

Dapsone.

List of References

Lactation sources: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/1. Waters MFR. G 30 320 or B 663–Lampren (Geigy). A working party held at the Royal Garden Hotel London, September 1968. Lepr Rev. 1969;40 (1):21-47. PMID: 4888382
2. Freerksen E, Seydel JK. Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimine. Arzneimittelforschung. 1992;42:1243-5. PMID: 1472145
3. Venkatesan K, Mathur A, Girdhar A et al. Excretion of clofazimine in human milk in leprosy patients. Lepr Rev. 1997;68:242-6. PMID: 9364825
4. Browne SG, Hogerzeil LM. B 663 in the treatment of leprosy: preliminary report of a pilot trial. Lepr Rev. 1962;33:6-10. PMID: 13873759
5. Drobac PC, del Castillo H, Sweetland A et al. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis. 2005;40:1689-92. PMID: 15889370
6. Ozturk Z, Tatliparmak A. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature. Dermatol Ther. 2017;30:e12414. PMID: 27549245

Disclaimer: This material is provided for educational purposes only and is not intended for medical advice, diagnosis, or treatment. Consult your healthcare provider with any questions.

Read This Next

Dapsone

Dapsone and pregnancy or breastfeeding: Is it safe?

Read More

As seen in

Join our mailing list

Sign up for access to exclusive promotions, latest news and opportunites to test new pre-release products